In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 166591-85-1, name is 2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, introducing its new discovery. Safety of 2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid
Preparation method of 1, 4 – butanediol and dicarboxylic acid ester thereof (by machine translation)
The present invention relates to 1, 4 – butanediol and a preparation method. In particular, 1, 4 – butanediol and the dicarboxylic acid ester thereof include the following steps: a bran acid compound, a trifluoromethanesulfonate, and a hydrogenation catalyst are subjected to hydrodecarbonylation in a carboxylic acid solvent to give 1, 4 – butanediol dicarboxylate. The method has the characteristics, simple process, easiness in purification, high yield, environmental friendliness and the like, and is suitable for large-scale industrial production. (by machine translation)
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 166591-85-1, and how the biochemistry of the body works.Safety of 2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid
Reference£º
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem